These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30929848)

  • 1. Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.
    Solanki AA; Bossi A; Efstathiou JA; Lock D; Mondini M; Ramapriyan R; Welsh J; Kang J
    Eur Urol Oncol; 2019 Feb; 2(1):79-87. PubMed ID: 30929848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies.
    Ukleja J; Kusaka E; Miyamoto DT
    Front Oncol; 2021; 11():663852. PubMed ID: 34041029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
    Maisch P; Koll F; Bolenz C; Chun FK; Gschwend JE; Schmid SC
    Urol Oncol; 2023 May; 41(5):219-232. PubMed ID: 36372634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers.
    Saidian A; Dolendo I; Sharabi A; Stewart TF; Rose B; McKay RR; Bagrodia A; Salmasi A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunotherapy combinations for genitourinary cancers.
    Al Harthy M; Redman J; Madan RA
    Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergy between ionizing radiation and immunotherapy in the treatment of prostate cancer.
    Sathianathen NJ; Krishna S; Konety BR; Griffith TS
    Immunotherapy; 2017 Sep; 9(12):1005-1018. PubMed ID: 28971750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors in genitourinary malignancies.
    Thana M; Wood L
    Curr Oncol; 2020 Apr; 27(Suppl 2):S69-S77. PubMed ID: 32368176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
    Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN
    J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations.
    Lei H; Shi M; Xu H; Bai S; Xiong X; Wei Q; Yang L
    Cancer Manag Res; 2021; 13():1719-1731. PubMed ID: 33658847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies.
    Pignot G; Loriot Y; Kamat AM; Shariat SF; Plimack ER
    Eur Urol Oncol; 2019 Jul; 2(4):355-364. PubMed ID: 31277773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and overcoming resistance to immunotherapy in genitourinary cancers.
    Evans ST; Jani Y; Jansen CS; Yildirim A; Kalemoglu E; Bilen MA
    Cancer Biol Ther; 2024 Dec; 25(1):2342599. PubMed ID: 38629578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with radiotherapy in urological malignancies.
    Mehta S; Illidge T; Choudhury A
    Curr Opin Urol; 2016 Nov; 26(6):514-22. PubMed ID: 27552139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
    Heidegger I; Necchi A; Pircher A; Tsaur I; Marra G; Kasivisvanathan V; Kretschmer A; Mathieu R; Ceci F; van den Bergh RCN; Thibault C; Tilki D; Valerio M; Surcel C; Gandaglia G;
    Eur Urol Oncol; 2021 Oct; 4(5):745-754. PubMed ID: 33243663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combining radiotherapy with immunotherapy for urological malignancies].
    Rieken S; El Shafie R
    Urologe A; 2018 Nov; 57(11):1309-1315. PubMed ID: 30324394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunotherapy revolution in genitourinary malignancies.
    U Gandhy S; Madan RA; Aragon-Ching JB
    Immunotherapy; 2020 Aug; 12(11):819-831. PubMed ID: 32594815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors.
    Zhu N; Weng S; Wang J; Chen J; Yu L; Fang X; Yuan Y
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3021-3036. PubMed ID: 31617075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
    Lee L; Matulonis U
    Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.